Update on the diagnosis and treatment of alcoholic dilated cardiomyopathy
Keywords:
alcohol; alcoholic dilated cardiomyopathy; diagnosis; heart failure; treatmentAbstract
Introduction: Alcoholic dilated cardiomyopathy is a significant cause of non-ischemic heart failure resulting from chronic and excessive alcohol consumption. Although advances in elucidating its pathophysiological mechanisms are notable, early diagnosis and adequate treatment continue to present challenges in high-risk groups.
Objective: To update recent evidence on the pathophysiology, diagnosis, and treatment of alcoholic dilated cardiomyopathy.
Methods: A bibliographic review (2018-2025) was conducted according to PRISMA guidelines in PubMed, SciELO, and Cochrane. Out of 178 identified records, 27 studies (ESC guidelines, observational/prospective) were selected after title/abstract and full-text evaluation. Quality was assessed using GRADE/Newcastle-Ottawa scales. A narrative synthesis with critical analysis of reported statistical measures was performed.
Development: Alcoholic dilated cardiomyopathy results from direct myocardial damage induced by ethanol and oxidative stress, with nonspecific clinical manifestations. Its diagnosis requires a history of high alcohol consumption, echocardiographic evidence of ventricular dilatation and systolic dysfunction, and the exclusion of other cardiomyopathies. Abstinence is the cornerstone of treatment, complemented by standard pharmacotherapy for heart failure. A multidisciplinary management approach involving cardiology, addiction medicine, and psychosocial support is essential to optimize prognosis.
Conclusions: Alcoholic dilated cardiomyopathy requires a comprehensive approach that combines prevention, timely diagnosis, and standardized pharmacological treatment. Alcohol abstinence is crucial for the reversibility of ventricular dysfunction. The need for public policies to reduce its incidence and promote research into specific therapeutic targets is emphasized.
Downloads
References
1. Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C, et al. Guidelines for the management of cardiomyopathies [Internet]. Eur Heart J. 2023; 44(37):3503-26. DOI: 10.1093/eurheartj/ehad194
2. Figueredo VM, Patel A. Detrimental effects of alcohol on the heart: hypertension and cardiomyopathy [Internet]. Rev Cardiovasc Med. 2023; 24(10): 292. DOI: 10.31083/j.rcm2410292
3. Georgescu OS, Martin L, Târtea GC, Rotaru-Zavaleanu AD, Dinescu SN, Vasile RC, et al. Alcohol Consumption and Cardiovascular Disease: A Narrative Review of Evolving Perspectives and Long-Term Implications [Internet]. Life. 2024; 14(9)1134. DOI: 10.3390/life14091134
4. Albakri A. Alcoholic cardiomyopathy: A review of literature on clinical status and meta-analysis of diagnostic and clinical management methods [Internet]. Clin Med Invest. 2018; 3(3): 2-14. DOI: 10.15761/CMI.1000165
5. Gróny A, Wójcik A, Chwiejczak J, Obrebski M, Koscian J, Mlynarska J, et al. Alcoholic Cardiomyopathy: a summary of current knowledge and possible future directions [Internet]. Journal of Education, Health and Sport. 2024; 69: 49619. DOI: 10.12775/JEHS.2024.69.49619
6. Domínguez F, Adler E, García-Pavía P. Alcoholic cardiomyopathy: an update [Internet]. Eur Heart J. 2024; 45(24):2294-305. DOI: 10.1093/eurheartj/ehae362
7. Vázquez-Ramírez EM, Mata-Vicente JF. Cardiomiopatía secundaria al consumo de alcohol [Internet]. Med Int Méx. 2016 [acceso: 11/01/2026]; 32(1):93-102. Disponible en: https://www.medigraphic.com/pdfs/medintmex/mim-2016/mim161l.pdf
8. Ely M, Hardy R, Longford NT, Wadsworth ME. Gender differences in the relationship between alcohol consumption and drink problems are largely accounted for by body water [Internet]. Alcohol Alcohol. 1999; 34(6):894-902. DOI: 10.1093/alcalc/34.6.894
9. Edavettal JM, Harris NR, Cohen SE, Paloczi J, Chandrasekar B, Gardner JD. Abstinence Restores Cardiac Function in Mice with Established Alcohol-Induced Cardiomyopathy [Internet]. Cells. 2023; 12(24):2783. DOI: 10.3390/cells12242783
10. Piano MR, Marcus GM, Aycock DM, Buckman J, Hwang CL, Larsson SC, et al. Alcohol use and cardiovascular disease: a scientific statement from the American Heart Association [Internet]. Circulation. 2025; 152(1):7-21. DOI: 10.1161/CIR.0000000000001341
11. Duarte-Segura N, Bonilla- Carrión R, Álvarez-Pineda MF, Evans-Meza R, Salvatierra- Durán R. Mortalidad por miocarditis alcohólica en América Latina, 2000-2019 [Internet]. Rev Hisp Cienc Salud. 2023; 9(2):69-84. DOI: 10.56239/rhcs.2023.92.639
12. Hamala P, Wierzbowska-Drabik K. Alcohol impact on the heart and cardiovascular system - hypertrophy, remodeling and strain impairment - contemporary state-of-the-art [Internet]. Rev Argent Cardiol. 2023; 91(1):70-78. DOI: 10.7775/rac.es.v91.i1.20592
13. Mouton AJ, El Hajj EC, Ninh VK, Siggins RW, Gardner JD. Inflammatory cardiac fibroblast phenotype underlies chronic alcohol- induced cardiac atrophy and dysfunction [Internet]. Life Sci.2020; 245: 117330. DOI: 10.1016/j.lfs.2020.117330
14. Orozco SP, Tobón J M, Gómez J P, Murgas CH, Rico M J, Calderón G, et al. Relación Y Características Epidemiológicas De La Cardiomiopatía Dilatada En Pacientes Con Cirrosis Hepática [Internet]. Ciencia Latina Revista Científica Multidisciplinar. 2024; 8(3): 6680-91. DOI: 10.37811/cl_rcm.v8i3.11865
15. Andersson C, Schou M, Gustafsson F, Torp-Pedersen C. Alcohol intake in patients with cardiomyopathy and heart failure: consensus and controversy [Internet]. Circ Heart Fail. 2022; 15(8):e009459. DOI: 10.1161/circheartfailure.121.009459
16. Askanas A, Udoshi M, Sadjadi SA. The heart in chronic alcoholism: a noninvasive study [Internet]. Am Heart J. 1980; 99(1):9-16. DOI: 10.1016/0002-8703(80)90309-9
17. Wang Y, Li G, Sun Y, Shan G, Xu R, Guo L. Left ventricular strain and rotation by 2-D speckle tracking echocardiography identify early alcoholic cardiomyopathy [Internet]. Ultrasound Med Biol. 2016; 42(8):1741–49. DOI: 10.1016/j.ultrasmedbio.2016.03.023
18. Porcari A, Baggio C, Fabris E, Merlo M, Bussani R, Perkan A, et al. Endomyocardial biopsy in the clinical context: current indications and challenging scenarios [Internet]. Heart Fail Rev. 2023; 28(1):123-35. DOI: 10.1007/s10741-022-10247-5
19. Falcao- Pires I, Ferreira AF, Trindade F, Bertrand L, Ciccarelli M, Visco V, et al. Mecanismos de remodelación miocárdica inversa y su significado clínico: Declaración del Grupo de Trabajo del Comité de la Función miocárdica [Internet]. European Journal of Heart Failure. 2024; 26(7): 1454-79. DOI: 10.1002/ejhf.3264
20. Brdgar A, Taha M, Awan A, Ogunti R, Garbin J, Hamad M, et al. The burden of substance use disorders among hospitalized patients with underlying cardiovascular or cerebrovascular disease in the United States [Internet]. J Vasc Surg. 2022; 10(6):462. DOI: 10.35248/2329-6925.22.10.462
21. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. ESC Scientific Document Group. ESC guidelines on cardiovascular disease prevention in clinical practice [Internet]. Eur Heart J. 2021; 42(34):3227-337. DOI: 10.1093/eurheartj/ehab484
22. Farokhnia M, Rentsch CT, Chuong V, McGinn MA, Elvig SK, Douglass EA, et al. Spironolactone as a potential new pharmacotherapy for alcohol use disorder: convergent evidence from rodent and human studies [Internet]. Molecular Psychiatry. 2022; 27(11): 4642–52. DOI: 10.1038/s41380-022-01736-y
23. Akbar RA, Lirani EA, Hasan MRD. Alcohol induced cardiomyopathy in non-alcoholic society: a case report of determining the etiology of dilated cardiomyopathy [Internet]. Sch J Med Case Rep. 2022; 10(4):348-56. DOI: 10.36347/sjmcr.2022.v10i04.020
24. Antonopoulos AS, Kasiakogias A, Kouroutzoglou A, Touloupaki M, Briasoulis A, Papatheodorou E, et al. Atrial fibrillation burden and management in cardiomyopathies: Current evidence and unmet needs [Internet]. Trends Cardiovasc Med. 2025; 35(5):284-93. DOI: 10.1016/j.tcm.2025.01.007
25. Haber PS, Riordan BC, Winter DT, Barrett L, Saunders J, Hides L, et al. New Australian guidelines for the treatment of alcohol problems: an overview of recommendations [Internet]. Med J Aust. 2021; 215(7):1-32. DOI: 10.5694/mja2.51254
26. Valdez P, Cortese S, Risso M, Puello H, Casariego E, Diaz Salazar L, et al. Alcohol y enfermedad cardiovascula [Internet]. Medicina (Buenos Aires). 2023 [acceso: 11/01/2026]; 83(Supl I):23-6. Disponible en: https://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802023000100023&lng=es
27. Valente F, Pozzi M, Sebbag L, Baudry G. Left Ventricular Assist Device as a Bridge-to-Recovery Strategy in Alcoholic Cardiomyopathy: A Case Series [Internet]. Canadian Journal of Cardiology. 2025; 41(4):764–67. DOI: 10.1016/j.cjca.2024.08.278
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Arlet Payrol Pérez, Laura Caridad Hurtado Gascón, Leister Gerardo Acosta Queralta

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who have publications with this Journal accept the following terms:
- The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
- The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
- Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.

